ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q2SCImago #10,309Hybrid

Journal of Drug Issues

Identifier (ISSN):0022-0426(Print)/1945-1369(Online)
•
Publisher:SAGE
Clarivate JCR Index Advisory: Active (SSCI)
Clarivate IF (2026)
1.5↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2022–2026)

Clarivate IF trend for Journal of Drug Issues

WoS Q4
01231.6720221.720231.220241.220251.52026
Annual Impact Factor Metric
Current (2026):1.5
Scopus SJR & RankScopus Q2
0.575
#10,309

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
64

64 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate8.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
42articles/year
21.29% Gold OA•98.28% Original Research

Aims & Scope

The Journal of Drug Issues (JDI) was incorporated as a nonprofit entity in the State of Florida in 1971. In 1996, JDI was transferred to the Florida State University College of Criminology and Criminal Justice, and the Richard L. Rachin Endowment was established to support its continued publication. Since its inception, JDI has been dedicated to providing a professional and scholarly forum centered on the national and international problems associated with drugs, especially illicit drugs. It is a refereed publication with international contributors and subscribers. As a leader in its field, JDI is an instrument widely used by research scholars, public policy analysts, and those involved in the day-to-day struggle against the problem of drug abuse.

Topics Covered (Recognized by AI)
Psychology92.5%Medicine84.7%Psychiatry67.9%Biology63.6%Sociology56.4%Political science51.9%Law44.4%Pharmacology38.5%Drug32.4%Criminology30.5%Psychotherapist30.3%Computer science29.2%Philosophy27%Economics26%Mathematics24.9%Clinical psychology24.2%Environmental health24.1%Social psychology23.3%Internal medicine20.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSSCI2026

SUBSTANCE ABUSE

Q4
Rank47/61
IndexSSCI
JCISSCI2026

SUBSTANCE ABUSE

Q4
Rank47/61
IndexSSCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.5
Articles / Year27
Total Citations0
2025
IF1.2
Articles / Year54
Total Citations21
2024
IF1.2
Articles / Year49
Total Citations87
2023
IF1.7
Articles / Year54
Total Citations240
2022
IF1.67
Articles / Year59
Total Citations344

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,309Scopus Q2SCImago Profile
Scopus Coverage:1971-2026
Scopus Broad Areas:MedicineSocial Sciences
Scopus Citation Rank (SJR)Q2
0.575

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.95

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,916 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations220
3-Year Documents113
Citable Documents113

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate60.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Health (social science)Q2
Medicine (miscellaneous)Q2
Psychiatry and Mental HealthQ2
Public Health, Environmental and Occupational HealthQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 8.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区SUBSTANCE ABUSE
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Drug Issues (ISSN: 0022-0426) is a peer-reviewed international scholarly journal in the field of SUBSTANCE ABUSE, published by SAGE in United States. The periodical holds a Journal Impact Factor (JIF) of 1.50, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.575 (Q2), an H-index of 64.

The journal enforces rigorous peer evaluation with an annual output of approximately 42 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,916 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
SAGE
Publication Language
English
Frequency
Periodic
Indexing & Databases
SSCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f8d8c517-7be2-490d-bb60-ba06d1b35c79
Database Updated: 2026-10-01